Internal Medicine, Rheumatology · Boone, NC
NPI
1689675175
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
148 Highway 105 Ext, Suite 104
Boone, NC, 28607
Phone (828) 386-2746
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.9M
141,174 services
Medicare patients, 2024
438
Average age 73
Drug cost, 2024
$7.4M
6,642 prescriptions
Company payments, 2025
$2,547
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James W Logan was code J3262 (injection, tocilizumab, 1 mg), 59,534 times for 13 patients. In total James W Logan billed 141,174 services in 57 codes, and Medicare paid $1.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 59,534 | 13 | $4.70 | $280K |
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 29,402 | 11 | $3.60 | $106K |
| J0897 Injection, denosumab, 1 mg | Office | 10,740 | 118 | $20.18 | $217K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 4,200 | 45 | $0.10 | $414 |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 4,120 | 12 | $24.66 | $102K |
| 96372 Injection Administration | Office | 466 | 166 | $10.69 | $4,980 |
| 99214 Office E&M - Established | Office | 380 | 223 | $83.68 | $32K |
| 96365 Intravenous Infusion, Hydration | Office | 273 | 63 | $44.77 | $12K |
| 36415 Venipuncture Blood Collection | Office | 231 | 159 | $8.54 | $1,973 |
| 99213 Office E&M - Established | Office | 193 | 151 | $55.20 | $11K |
| 96415 Chemotherapy Administration | Office | 111 | 21 | $20.17 | $2,239 |
| J3489 Injection, zoledronic acid, 1 mg | Office | 105 | 21 | $4.84 | $508 |
| 96413 Chemotherapy Administration | Office | 99 | 22 | $92.72 | $9,179 |
| 20610 Joint Injection | Office | 67 | 37 | $55.93 | $3,748 |
| 20600 Joint Injection | Office | 26 | 13 | $31.90 | $829 |
By year: 2022 $2.3M for 116,075 services; 2023 $2.2M for 138,120 services; 2024 $1.9M for 141,174 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 231 | 159 | $8.54 | $1,973 |
Medicare prescription drug claims, 2024
In 2024, the drug James W Logan prescribed most often to Medicare patients was Prednisone, with 787 prescriptions and refills. In total James W Logan wrote 6,642 Medicare prescriptions that cost $7.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 787 | 1,277 | 174 | $5,408 |
| Methotrexate Methotrexate Sodium | 552 | 988 | 111 | $9,079 |
| Hydroxychloroquine Sulfate Generic | 484 | 801 | 96 | $12K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 383 | 383 | 45 | $11K |
| Celecoxib Generic | 300 | 445 | 63 | $8,707 |
| Tramadol Hcl Generic | 276 | 286 | 50 | $2,327 |
| Pregabalin Generic | 273 | 291 | 41 | $2,997 |
| Tizanidine Hcl Generic | 231 | 348 | 70 | $3,259 |
| Meloxicam Generic | 209 | 307 | 48 | $681 |
| Humira(Cf) Pen Adalimumab | 196 | 196 | 20 | $1.3M |
| Gabapentin Generic | 189 | 271 | 38 | $2,746 |
| Cyclobenzaprine Hcl Generic | 186 | 226 | 44 | $1,802 |
| Leflunomide Generic | 148 | 234 | 38 | $6,109 |
| Rinvoq Upadacitinib | 121 | 121 | 19 | $766K |
| Enbrel Mini Etanercept | 116 | 121 | 14 | $883K |
Brand drugs: 1,090 claims; generic drugs: 5,552 claims; opioid claims: 874.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James W Logan $2,547 ($2,547 in general payments such as food, travel and fees) from 15 companies. The largest payer was Amgen Inc. with $464.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 25 | $464 |
| UCB, Inc. UCB.BR | 24 | $345 |
| Abbvie Inc. ABBV | 21 | $305 |
| Novartis Pharmaceuticals Corporation NVS | 15 | $274 |
| Janssen Biotech, Inc. JNJ | 15 | $258 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $244 |
| Pfizer Inc. PFE | 14 | $183 |
| Radius Health, Inc. | 5 | $126 |
| Novo Nordisk Inc NVO | 5 | $102 |
| ANI Pharmaceuticals, Inc. ANIP | 3 | $80.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.